Delivery Order SPE2DB22D2005-SPE2DB24FJSS2

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has a firm fixed price of $30,541.60 and a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,076.52 firm fixed-price contract is for the delivery of 4,566,043,778 units of the prescription drug Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $11,544.06, is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has a completion date of September 24, 2024 and is a Firm Fixed Price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,202.93 and covers the delivery of Losartan-HCTZ 100-12.5 mg tablets over a period ending on December 21, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for 50/12.5 mg losartan-HCTZ tablets. The $31,460.64 firm fixed price delivery order contract has a completion date of May 9, 2024 and is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a broad range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,544.11, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. This is a firm-fixed-price delivery order contract with a performance period extending to May 29, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,303.08, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a completion date of May 16, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets. The contract is a firm-fixed-price arrangement with a ceiling value of $7,351.95 and an ultimate completion date of August 14, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,153.53, is for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,178,710 units of the generic drug Losartan-HCTZ 100-25 mg tablets in 90-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,009.44 and a completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJSS2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The $20,986.67 firm fixed price contract has a completion date of September 16, 2024 and is not set aside for any specific business type.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The company also has an IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for providing similar pharmaceutical and medical supplies. These established IDCs enable efficient procurement of essential medical products from Amerisourcebergen to support the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations.

Generated 12/13/24, 9:40 AM